Tocilizumab Exerts Anti-Tumor Effects on Colorectal Carcinoma Cell Xenografts Corresponding to Expression Levels of Interleukin-6 Receptor

• Main Authors: Yuan-Chiang Chung (Author), Szu-Jung Chen (Author), Chiu-Chen Huang (Author), Wei-Chun Liu (Author), Ming-Tsung Lai (Author), Ting-Yu Kao (Author), Wei-Shun Yang (Author), Chien-Hui Yang (Author), Chih-Ping Hsu (Author), Jia-Feng Chang (Author)
• Format: Book
• Published: MDPI AG, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The use of tocilizumab against the interleukin-6 receptor (IL-6R) has been demonstrated as inhibiting the progression of diverse cancers in vitro and in vivo. Nonetheless, evidence regarding the anti-tumor effects of tocilizumab on human colorectal carcinoma (CRC) corresponding to IL-6R expression l...